Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

Clinical trial NCT04767373 · COMPLETED

Trial details

NCT number: NCT04767373
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infection

Start date: 2021-04-07
Primary completion: 2024-07-09
Enrollment: 3632

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.